A Win For Kala Pharmaceuticals, Inc.
Thu, Dec 29, 2022 at 07:12 PM
Kala Pharmaceuticals, Inc. (KALA:NASDAQ) soared at $24.84, a gain of 99%. On Thu, Dec 29, 2022, KALA:NASDAQ hit a New 2-Week High of $24.84. The stock appeared on our News Catalysts scanner on Wed, Dec 28, 2022 at 02:12 PM in the 'BIOTECH' category. From Thu, Dec 15, 2022, the stock recorded 44.44% Up Days and 40.00% Green Days
About Kala Pharmaceuticals, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 143.64%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 99.04%
- Palisade Bio Inc. (PALI:NASDAQ), 77.9%
- SatixFy Communications Ltd. (SATX:NYSEMKT), 67.68%
- First Wave BioPharma Inc. (FWBI:NASDAQ), 61.22%
- Baudax Bio, Inc. (BXRX:NASDAQ), 56.09%
- Quotient Limited (QTNT:NASDAQ), 54.13%
- Starry Group Holdings Inc. Class A (STRY:NYSE), 49.75%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 45.57%
- Sonendo Inc. (SONX:NYSE), 39.11%